SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SLXP Analysis & Videos »
SLXP: Bull or Bear?
FDA, Clinical Trial News: $ABIO, $GENZ, $KV-A, $SLXP
SLXP
|
|
|
+43.56%
in
802 days
<> <font> Shares of ARCA biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing. ABIO also reported that it has submitted a revised pivotal study protocol to the FDA on 3/25/10 under the SPA process and could begin the study in approximately one year, contingent upon the FDA response and adequate funding. </font> <> <font> Shares of Genzyme (NASDAQ:GENZ) are rebounding today following a drop of approximately 10% for the week on news earlier this week that the FDA w...
|
FDA, Clinical Trial Calendar Updates: WYE, SVNT, AMRN, ISIS, SLXP, SOMX
SLXP
|
|
|
+238.93%
in
323 days
(closed on 03/26/10)
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
|
Challenges for Sell-Rated Salix
SLXP
-583.96%
in
1462 days
We expect 2008 to be an extremely challenging year for the company with a significant decline in both revenues and earnings.
|
Pressures Keep Salix a Sell
SLXP
-16.48%
in
27 days
(closed on 06/03/08)
We expect 2008 to be an extremely challenging year for the company with a significant decline in both revenues and earnings.
|
People Bullish on SLXP
People Bearish on SLXP
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on SLXP |
Be the first to start a discussion and earn 2 points.
More Resources
|
About Salix Pharmaceuticals Ltd.
- Answers.com
